|
NVOS Novo Integrated Sciences Inc 1138978 |
| Income Statement |
|
Revenue
|
form10-k
|
13,294,357 |
|
Net Income
|
form10-k
|
-16,166,744 |
|
Profit Margin
|
|
-121.61% |
| Balance Sheet |
|
Current Assets
|
5,414,850 |
|
Assets
|
32,141,276 |
|
Current Liabilities
|
14,579,412 |
|
Liabilities
|
17,527,351 |
|
Equity
|
14,613,925 |
|
Shares Out
|
19,055,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,069,840 |
|
Investing Cash Flow
|
-5,034 |
| Market Analysis |
Market Cap
|
6,276,943 |
|
Price
|
0.05 |
|
BVPS
|
0.77 |
|
PB
|
0.07 |
|
EPS
|
-1.38 |
|
PS
|
0.12 |
|
FCF
|
-5,074,874 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NVOS documents filed with the SEC.
NVOS Filings
Clear
